1.van Herk T, Brussee J, van den Nieuwendijk AM, van der Klein PA, IJzerman AP, Stannek C, Burmeister A, Lorenzen A.. (2003) Pyrazole derivatives as partial agonists for the nicotinic acid receptor., 46 (18):[PMID:12930155][10.1021/jm030888c]
2.Gharbaoui T, Skinner PJ, Shin YJ, Averbuj C, Jung JK, Johnson BR, Duong T, Decaire M, Uy J, Cherrier MC, Webb PJ, Tamura SY, Zou N, Rodriguez N, Boatman PD, Sage CR, Lindstrom A, Xu J, Schrader TO, Smith BM, Chen R, Richman JG, Connolly DT, Colletti SL, Tata JR, Semple G.. (2007) Agonist lead identification for the high affinity niacin receptor GPR109a., 17 (17):[PMID:17588745][10.1016/j.bmcl.2007.06.028]
3.PubChem BioAssay data set,
4.PubChem BioAssay data set,
5.Johansson NG, Turku A, Vidilaseris K, Dreano L, Khattab A, Ayuso Pérez D, Wilkinson A, Zhang Y, Tamminen M, Grazhdankin E, Kiriazis A, Fishwick CWG, Meri S, Yli-Kauhaluoma J, Goldman A, Boije Af Gennäs G, Xhaard H.. (2020) Discovery of Membrane-Bound Pyrophosphatase Inhibitors Derived from an Isoxazole Fragment., 11 (4):[PMID:32292570][10.1021/acsmedchemlett.9b00537]
6.Messore A, Corona A, Madia VN, Saccoliti F, Tudino V, De Leo A, Scipione L, De Vita D, Amendola G, Di Maro S, Novellino E, Cosconati S, Métifiot M, Andreola ML, Valenti P, Esposito F, Grandi N, Tramontano E, Costi R, Di Santo R.. (2020) Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase., 11 (5):[PMID:32435387][10.1021/acsmedchemlett.9b00617]